Common Warrants and Pre Funded Warrants (Tables) |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2026 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Class of Warrant or Right [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Summary of 2023 Common Warrant Liability | The following table sets forth a summary of the activities of the Company’s 2023 Common Warrant liability, which represents a recurring measurement that is classified with Level 3 of the fair value hierarchy wherein the fair value is estimated using significant unobservable inputs (in thousands):
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2023 and 2025 Pre-Funded Warrants [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Class of Warrant or Right [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Summary of Pre-funded Warrant Shares Outstanding | The following table summarizes information about shares issuable under the 2023 and 2025 Pre-Funded Warrants outstanding at December 31, 2025 and September 30, 2026:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2023 and 2025 Common Warrants [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Class of Warrant or Right [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Summary of Common Warrant Shares Outstanding | The following table summarizes information about shares issuable under the 2023 and 2025 Common Warrants outstanding at September 30, 2026: Common warrant shares outstanding
September 30, 2026
December 31, 2025
Outstanding at the beginning of the year
4,213,767
2,200,858
Issued
-
2,012,909
Exercised
-
-
Outstanding at the end of the period
4,213,767
4,213,767
Exercisable at the end of the period
4,213,767
4,213,767 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2023 Common Warrants [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Class of Warrant or Right [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Summary of Assumptions Used to Determine the fair value at Issuance and Reporting Date of Common Warrants Granted | The assumptions that the Company used to determine the fair value at the reporting date were as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||